Neurology Neuroscience Parkinson's Regenerative Medicine stem cells Stem cells can repair Parkinson’s-damaged circuits in mouse brains By Staff Reports 12 months ago The mature brain is infamously bad at repairing itself following damage like that caused by
Antibiotics Biotechnology Coronavirus Coronavirus COVID-19 Immunotherapies Infection Control Infectious Diseases Some Severe COVID-19 Cases Linked to Genetic Mutations or Antibodies that Attack the Body By Staff Reports 12 months ago People infected by the novel coronavirus can have symptoms that range from mild to deadly.
Uncategorized National Institute of Health Funds Novel Therapeutic For Pregnant Women Affected by Chorioamnionitis By Staff Reports 1 year ago Aqualung Therapeutics, an early-stage biotech company developing an immune-focused, anti-inflammatory therapeutic platform for unchecked inflammation
Biotechnology Immunotherapies Regulatory T cells could lead to new immunotherapies aimed at treating multiple sclerosis By Staff Reports 1 year ago In a new University of California, Irvine-led study, researchers have discovered how regulatory T cells
Biotechnology cancer Cancer Discovery Cell Therapy Clinical Trials Study Reinforces Benefit Using Targeted Therapy for Early Stage NSCLC By Staff Reports 1 year ago According to updated findings led by researchers at Yale Cancer Center, treatment with the targeted
Biotechnology Cardiology Clinical Trials Coronavirus Coronavirus COVID-19 drug development Infectious Diseases rare diseases Potential new drug to mitigate SARS-CoV-2 infection consequences By Staff Reports 1 year ago Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting By Staff Reports 1 year ago Eli Lilly and Company said proof of concept data from an interim analysis of the
Biotechnology cancer CU Researchers Come Together to Better Understand Ovarian Cancer Tumors and Treatment Outcomes By Staff Reports 1 year ago After nearly four years of work, a group of researchers and clinicians from the University
Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Antibody responses in COVID-19 patients could guide vaccine design By Staff Reports 1 year ago A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the
Biotechnology Breast Cancer cancer Clinical Trials Scientists Identify New Way To Target Some Rapidly Dividing Cancer Cells, Leaving Healthy Cells Unharmed By Staff Reports 1 year ago Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a
Coronavirus COVID-19 Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19 By Staff Reports 1 year ago Early findings from researchers at Children’s Hospital of Philadelphia (CHOP)show that convalescent plasma appears to be
Coronavirus COVID-19 AstraZeneca COVID-19 vaccine study halted after ‘potentially unexplained’ illness By Staff Reports 1 year ago (AP) Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company
cancer Innovative, minimally invasive treatment can help maintain prostate cancer patients’ quality of life By Staff Reports 1 year ago For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these
Coronavirus COVID-19 Obese patients at high risk of severe COVID-19 illness, study finds By Staff Reports 1 year ago BLOOMBERG — Obese and overweight people are at high risk of suffering severe cases of
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Vaccines Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses By Staff Reports 1 year ago Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show
Biotechnology cancer Clinical Trials drug development New Treatment Developed by Children’s Hospital of Philadelphia Shows Success in High-Risk Solid Tumors By Staff Reports 1 year ago Despite intensive treatment, high-risk solid tumors like neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma are challenging to
Biotechnology cancer Clinical Trials Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations By Staff Reports 1 year ago In a Phase II trial led by researchers at The University of Texas MD Anderson
Uncategorized Breakthrough led by NUS researchers provides new potential therapies for osteoporosis By Staff Reports 1 year ago A research team from the National University of Singapore (NUS) has identified a new avenue
Biotechnology Coronavirus Coronavirus COVID-19 drug development UCI scientists get ‘initial hit’ in developing drug to treat COVID-19 By Staff Reports 1 year ago When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Vaccines CEL-SCI Announced Early Results with COVID 19 LEAPS Vaccine/Treatment By Staff Reports 1 year ago CEL-SCI Corporation announces that it has concluded animal experiments using its LEAPS COVID 19 conjugate